Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Muzafar A Macha

Showing results (31-40 of 81) with videos related to

Pageof 9
Sort By:
Journal of Experimental & Clinical Cancer Research : CR|November 11, 2021
Ubiquitin-specific peptidase 37: an important cog in the oncogenic machinery of cancerous cellsRavi Chauhan, Ajaz A Bhat, Tariq Masoodi, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|June 6, 2024
Therapeutic implications of signaling pathways and tumor microenvironment interactions in esophageal cancerInamu Rashid Khan, Hana Q Sadida, Sheema Hashem, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|October 17, 2014
Mucins in lung cancer: diagnostic, prognostic, and therapeutic implicationsImayavaramban Lakshmanan, Moorthy P Ponnusamy, Muzafar A Macha, et al.
Advances in Protein Chemistry and Structural Biology|January 27, 2023
Current and emerging biomarkers in ovarian cancer diagnosis; CA125 and beyondTarang Sharma, Sabah Nisar, Tariq Masoodi, et al.
Carcinogenesis|February 21, 2018
Emerging therapeutic potential of graviola and its constituents in cancersAsif Khurshid Qazi, Jawed A Siddiqui, Rahat Jahan, et al.
Current Pharmaceutical Design|January 16, 2020
Exploring Dysregulated Signaling Pathways in CancerSabah Nisar, Sheema Hashem, Muzafar A Macha, et al.
Journal of Translational Medicine|December 10, 2020
Non-invasive biomarkers for monitoring the immunotherapeutic response to cancerSabah Nisar, Ajaz A Bhat, Sheema Hashem, et al.
Seminars in Cancer Biology|March 12, 2022
Chemokines in triple-negative breast cancer heterogeneity: New challenges for clinical implicationsUmar Mehraj, Umar Mushtaq, Manzoor A Mir, et al.
Advances in Experimental Medicine and Biology|June 29, 2021
Recent Advances in Head and Neck Tumor Microenvironment-Based TherapyMuzafar A Macha, Nissar A Wani, Rais A Ganai, et al.
Journal of Experimental & Clinical Cancer Research : CR|June 20, 2019
Afatinib and Temozolomide combination inhibits tumorigenesis by targeting EGFRvIII-cMet signaling in glioblastoma cellsRaghupathy Vengoji, Muzafar A Macha, Rama Krishna Nimmakayala, et al.
Pageof 9

Showing results (31-40 of 81) with videos related to

Sort By:
Pageof 9
Journal of Experimental & Clinical Cancer Research : CR|November 11, 2021
Ubiquitin-specific peptidase 37: an important cog in the oncogenic machinery of cancerous cellsRavi Chauhan, Ajaz A Bhat, Tariq Masoodi, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|June 6, 2024
Therapeutic implications of signaling pathways and tumor microenvironment interactions in esophageal cancerInamu Rashid Khan, Hana Q Sadida, Sheema Hashem, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|October 17, 2014
Mucins in lung cancer: diagnostic, prognostic, and therapeutic implicationsImayavaramban Lakshmanan, Moorthy P Ponnusamy, Muzafar A Macha, et al.
Advances in Protein Chemistry and Structural Biology|January 27, 2023
Current and emerging biomarkers in ovarian cancer diagnosis; CA125 and beyondTarang Sharma, Sabah Nisar, Tariq Masoodi, et al.
Carcinogenesis|February 21, 2018
Emerging therapeutic potential of graviola and its constituents in cancersAsif Khurshid Qazi, Jawed A Siddiqui, Rahat Jahan, et al.
Current Pharmaceutical Design|January 16, 2020
Exploring Dysregulated Signaling Pathways in CancerSabah Nisar, Sheema Hashem, Muzafar A Macha, et al.
Journal of Translational Medicine|December 10, 2020
Non-invasive biomarkers for monitoring the immunotherapeutic response to cancerSabah Nisar, Ajaz A Bhat, Sheema Hashem, et al.
Seminars in Cancer Biology|March 12, 2022
Chemokines in triple-negative breast cancer heterogeneity: New challenges for clinical implicationsUmar Mehraj, Umar Mushtaq, Manzoor A Mir, et al.
Advances in Experimental Medicine and Biology|June 29, 2021
Recent Advances in Head and Neck Tumor Microenvironment-Based TherapyMuzafar A Macha, Nissar A Wani, Rais A Ganai, et al.
Journal of Experimental & Clinical Cancer Research : CR|June 20, 2019
Afatinib and Temozolomide combination inhibits tumorigenesis by targeting EGFRvIII-cMet signaling in glioblastoma cellsRaghupathy Vengoji, Muzafar A Macha, Rama Krishna Nimmakayala, et al.
Pageof 9